Archive - January 2019
Expanding the Limits of Shotgun Proteomics Using Micro-Pillar Array Columns and Data- Independent Acquisition Methods
PharmaTimes CROY 2019 – deadline extended
NICE approval for Verzenios in metastatic breast cancer
EU licence granted for Erleada in prostate cancer
Scholl and COP announce partnership
‘Innovative’ new disease and infection test
Evenity back on track with FDA panel blessing in osteoporosis
NICE gives Lilly’s Verzenios chance to compete with rivals